Biogen Inc
(BSP:BIIB34)
R$
169.49
1.36 (0.81%)
Market Cap: 149.37 Bil
Enterprise Value: 178.06 Bil
PE Ratio: 15.80
PB Ratio: 1.56
GF Score: 75/100 
Biogen Inc at SVB Leerink CNS Forum (Virtual) Transcript
Jun 29, 2021 / 05:50PM GMT
Release Date Price:
R$278.98
Marc Harold Goodman
SVB Leerink LLC, Research Division - MD of Neuroscience & Senior Research Analyst
All right. Good afternoon, everybody. I'm Marc Goodman with SVB Leerink. Thanks for joining us for our next session in our third annual CNS Forum, and we're lucky enough to have a company called Biogen join us here. And we have Chris Henderson, the Head of Research at Biogen. And Chris has been in this role a little over a year now, right? But you've been with the company probably 7-ish years.
Christopher Henderson
Biogen Inc. - VP & Head of Neuromuscular & Movement Disorders Research Unit
Yes.
Marc Harold Goodman
SVB Leerink LLC, Research Division - MD of Neuroscience & Senior Research Analyst
And so thanks again for joining us. And so we're going to cover a couple of areas probably in a little more detail than most people are probably familiar with it.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers